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 The antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus (MRSA) from in-patients 
and out-patients at the University of Port Harcourt Teaching Hospital (UPTH) was studied. Fifty, S. aureus organisms 
were isolated from routine clinical specimens such as high vaginal, wound, urethral and ear swabs. The organisms 
were identified morphologically and biochemically by standard laboratory procedures. MRSA screening was 
performed using oxacillin disc diffusion test and the effects of five antibiotics against the 50 S. aureus isolates were 
investigated. Eighteen (36%) of the isolates were methicillin (oxacillin) resistant, of these 12 (24%) were from in-
patients and 6 (12%) were from out patients. Eighty percent (80%) of the isolates were susceptible to Augumentin, 
78% to Ceftriaxone, 58% to Ceftazidime, 92% to Aprofloxacin, 94% to Vancomycin and 64% to Oxacilin. There is an 
emerging trend of vancomycin resistance among S. aureus isolates from UPTH. 
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INTRODUCTION 
 Staphylococcus aureus is associated with a 
variety of clinical infections including septicemia, 
pneumonia, urinary tract infections, wound sepsis, septic 
arthritis, osteomyelitis and post-surgical toxic shock 
syndrome with substantial rate of morbidity and mortality 
1
. One of the reasons for the success of this organism 
as a human pathogen is its great variability, occurring at 
different periods and places with diverse types and 
antibiotic resistance patterns within regions and 
countries. Hospital acquired Staphylococcal infections 
are common in newborn babies, surgical patients and 
hospital staff. Patients develop sepsis in wounds which 
result from operation procedures 
2
. Staphylococcus food 
poisoning can also occur. Attempts to control these 
diseases by chemotherapy through the use of 
antimicrobial agents particularly antibiotics have resulted 
in increased prevalence of resistance to these agents 
3
. 
Since the emergence of S. aureus strains with 
resistance to penicillin and methicillin in 1948 and 1961 
respectively, it has become a well known etiologic agent 
of a wide variety of infections and assumed increasing 
importance internationally as causative agent of both 
hospital and community acquired infections. The most 
notable example of the phenomenon of antibiotic 
resistance in Staphylococcus aureus was the 
emergence of methicillin resistant Staphylococcus 
aureus (MRSA) which was reported one year after the 
launch of methicillin antibiotic 
4
. MRSA is a bacterium 
responsible for difficult to treat infection in humans. The 
organism is often sub-categorized as community 
associated MRSA (CA-MRSA) or hospital associated 
MRSA (HA-MRSA) depending on the circumstance of 
acquiring disease 
5
. CA-MRSA strains are generally 





the typical, multiple-drug resistant HA-MRSA strains 
6
. 
This study was carried out to determine the frequency of 
MRSA isolates from different clinical specimens from in 
and out- patients of UPTH and to carry out a 
comparative study of the current antimicrobial 
susceptibility pattern of MRSA from these infections 
 
MATERIALS AND METHODS 
 Staphylococcus aureus isolates were collected 
from routine clinical samples of high virginal swab (HVS) 
wound swab (WS), ear swab (ES) and urethral swab 
(US) collected from the Department of Medical 
Microbiology, University of Port Harcourt Teaching 
Hospital (UPTH), Choba, Rivers-State, Nigeria. 
Isolation, characterization and identification of S. aureus 
was done as described by 
7
. Six antibiotics were bought 
from Fidson Health Care Limited (Lagos, Nigeria) and 
used in this study. They are Penicillin (betalactam), -
Oxacillin and Augmentin: Glycopeptides-Vancomycin: 
Fluoroquinolones- Ciprofloxacin and 3
rd
 generation 
antibiotics Cephalosporins Ceftriaxone and Ceftazidine. 
All confirmed S. aureus were tested for methicillin 
resistance using the Kirby-Bauer disc diffusion method 
using oxacillin disc (lug/disc) 
7
. 
The other 5 antimicrobial susceptibility test of all S. 
aureus isolates were also performed using the Kirby-
bauer disc diffusion method. All antibiotics used in the 
study are shown in Table 1. The pattern of susceptibility 
or resistance of the organism was interpreted on the 
basis of the presence or absence of definite zone of 
inhibition, interpreted using the zone size interpretation 
chart provided by Fibson Health Care Limited, Lagos 
Nigeria. The zone sizes of each antimicrobial agent 
against S.aureus were reported as resistant, 
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RESULT 
 A total of 50 S.aureus isolates were obtained, 
19 (38%) were recovered from WS, 15 (30%) from HVS, 
US yielded 9 (18%) and ES yielded, 7 (14%) (Table 2). 
Eighteen (36%) were methicillin-resistant (MRSA or 
Oxacillin resistant ORSA) while 32 (64%) were 
methicillin susceptible. Twenty-five (50%) of the fifty 
isolates were from in-patients while 50% were from out  
 
patients. Of the 18 MRSA, 12 (24%) were from in-
patients while 6 (12%) were from out-patients. Of the 32 
MSSA, 13(26%) were from in-patients and 19(38%) 
were from out patients (Table.1). Antimicrobial 
susceptibility data of the 50 S. aureus isolates are 
shown in Table 2. Fig 1 shows the percentage 
susceptibility of S.aureus to the various antibiotics used 




Table 1.0 Classes, Representatives, and Concentrations of antibiotics 
 
CLASSES  REPRESENTATIVES CONCENTRATIONS 
Penicilli (Beta-lactams) Oxacillin  and Agumentin 
(OX)                 (AUG) 
1ug/disc and 30ug/disc 
Glycopeptides Vancomycin (VA) 30ug/disc 





Ceftriaxone (CRO) and Ceftazidime 
(CAZ) 











Number AUG CRO CAZ CF VA OX 
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 The aim of this study was to investigate the 
frequency of MRSA from different clinical specimens 
from in and out patients of the UPTH and to carry out a 
comparative study of the current antimicrobial 
susceptibility pattern of MRSA and MSSA from these 
patients in this locality. Fifty S. aureus organisms were 
isolated from four clinical specimen. 18(36)% of these 
were MRSA and 32(64%) were MSSA. This observation 
is similar to that of Metha and his co-workers who 
reported a total of 33% MRSA and 67% MSSA from 
wound and pus swabs in their study “Control of MRSA in 
a tertiary care centre 
8
. This study recorded a higher  
prevalence of MRSA from in-patients than out-patients. 
This is probably because MRSA is considered a major 
nosocomical pathogen 
9
. The important reservoirs of 
MRSA in hospitals are infected or colonized patients. 
Unclean hands of health care workers is also a 
predominant mode for patient to patient transmission 
10
. 
Nineteen (38%) of the total number of isolates was 
recovered from wound swabs followed by 15 (30%) from 
HVS, 9(18%) from US and 7 (14%) from ES. The 
highest rate of MRSA isolates was recovered from 
wound swab specimens. 
11
 working in Canada reported 
that most of the patients with MRSA were older adults 
receiving care in medical or surgical units 
11
. The pattern 
has not changed as earlier reports by Swanston noted 
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more MRSA isolates from a surgical ward because of 
high usage of antibiotics in this facility 
12
. 
 MRSA infection on surgical wards is becoming 
increasingly common especially in critically ill patients 
who have spent prolonged periods in the intensive care 
unit 
13
.Though this study was not designed to identify 
risk factors for MRSA acquisition, the risk factors 
previously associated with acquisition of MRSA, in 
hospitals include broad-spectrum antimicrobial therapy, 
admission to an intensive care unit, old age and 
proximity to other patients with MRSA 
14
. In this study, 
94% of S. aureus isolated showed susceptibility to 
Vancomycin with a high percentage of intermediate 
susceptibility. This is similar but different from the 100% 
susceptibility observed in Swanston’s observation
12
. The 
decreased susceptibility to Vancomycin may be as a 
result of treatment failure by some strains reported in 
Japan and the United States of American
15
.Therefore it 
is advised that hospital use of Vancomycin must be 
reserved for only critical situations e.g MRSA to protect 
this antibiotic from emerging resistance. In one study on 
spectrum of antimicrobial resistance among MRSA, 
Ciprofloxacin resistance was as high as 98.9% (Qureshi 
et al, 2004). This is in contrast to the observations in this 
study in which only about 50% of the MRSA strains are 
resistant to Ciprofloxacin. This study also observed that 
80%, 75% and 55% of the isolates were susceptible to 
Augumentin, Cefraxome and Cetazidime respectively. 
The degree of resistance or susceptibility of MRSA to 
commonly used antibiotics is  therefore recognized to be 
diverse from region to region. Significantly, we observed 
that CA-MRSA strains tended to be susceptible to more 
antibiotics then HA-MRSA stains. This may be due to 
widespread indiscriminate use of antibiotics in the 
hospital environment. In conclusion, the degree of 
resistance or susceptibility of MRSA to commonly used 
antibiotics is different from region to region, with 
Vancomycin still the drug of choice for treating multi 
drug resistant MRSA infections. There is therefore the 
need to minimize the antibiotic pressure that favours the 
selection of resistant strains of organisms.This will help 
in controlling the emergence of Vancomycin Resistant 
Staphylococcus aureus (VRSA) in this hospital and the 
community. Ciprofloxacin can also be used in the 
management of MRSA infections in UPTH. This study 
recorded that 92% S. aureus were susceptible to 
Ciprofloxacin and a high percentage of the MRSA 
strains were also susceptible to this antibiotic.  
 To combat the increase in MRSA infections, in 
the hospitals and communities, a regular surveillance of 
hospitals and community associated infection, 
monitoring of antibiotic susceptibility pattern and 
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